CRISM Therapeutics Corporation

CRTX.L · LSE
Analyze with AI
£9.50+£0.00 (+0%)
At close:Dec 19, 2025, 5:28 PM UTC
P/E TTM-3.29
P/B TTM2.37
P/S TTM0
Dividend Yield0%
EPS-£0.04
Beta0.338
Valuation
PEG Ratio-0.03
FCF Yield-23.49%
EV / EBITDA-2.87
Quality
ROIC-69.45%
Gross Margin0.00%
Cash Conv. Ratio0.93
Growth
Revenue 3Y CAGR
FCF Growth65.31%
Safety
Net Debt / EBITDA0.30
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-2,158.71

CRISM Therapeutics Corporation (CRTX.L) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is CRISM Therapeutics Corporation (CRTX.L) stock price today?

As of Dec 19, 2025, 5:28 PM UTC, CRISM Therapeutics Corporation (CRTX.L) stock is trading at £9.50. The stock price is quoted in GBP and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CRTX.L stock quotes for informed trading decisions.

What is CRISM Therapeutics Corporation's market capitalization?

CRISM Therapeutics Corporation (CRTX.L) has a market capitalization of approximately $3.8M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare CRISM Therapeutics Corporation's size relative to other companies in the GBP market. The market cap figure updates automatically as the CRTX.L stock price changes.

What is the 52-week range for CRISM Therapeutics Corporation stock?

CRISM Therapeutics Corporation (CRTX.L) stock has traded in a 52-week range of £5.64 — £29.40. The 52-week range shows the highest and lowest prices at which CRTX.L traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current CRISM Therapeutics Corporation stock price to this range provides context for recent price action.

How much trading volume does CRISM Therapeutics Corporation stock have?

CRISM Therapeutics Corporation (CRTX.L) stock recently traded approximately 536.6K shares. Trading volume indicates market liquidity and investor interest in CRTX.L. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting CRISM Therapeutics Corporation stock.

Does CRISM Therapeutics Corporation pay dividends to shareholders?

Yes, CRISM Therapeutics Corporation (CRTX.L) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate CRISM Therapeutics Corporation stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is CRISM Therapeutics Corporation's intraday price range?

Today, CRISM Therapeutics Corporation (CRTX.L) stock has traded in a range of £9.15 — £9.94. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CRTX.L's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get CRISM Therapeutics Corporation stock data?

AlphaPilot sources real-time CRTX.L stock quotes, fundamental financial data, and historical price charts for CRISM Therapeutics Corporation from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The CRISM Therapeutics Corporation stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CRTX.L stock performance.